Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.
Researchers have identified a set of 22 proteins that distinguish multiple sclerosis from other inflammatory diseases.
Scientists from the Max Planck Institute of Biochemistry and the Technical University of Munich have discovered new diagnostic markers of multiple sclerosis (MS) in cerebrospinal fluid (CSF). This was ...
Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 Effective diagnosis, prognostication, ...
Cerebrospinal fluid (CSF) leaks represent a significant clinical challenge, marked by the aberrant escape of CSF from its usual confines into adjacent structures such as the paranasal sinuses, which ...
“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...
In addition to brain imaging, laboratory analysis of cerebrospinal fluid is important for the diagnosis of multiple sclerosis (MS). In this study, proteomic analysis of this fluid has revealed a set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results